Listed

Emergent BioSolutions Inc.: Form 10-K for the period ended Dec 31, 2011

Filed with the SEC on Mar 9, 2012 and accepted by EDGAR at Mar 9, 2012, 20:21 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2011-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Cost of revenue12 months2011-01-01 to 2011-12-31$42.2mus-gaap:CostOfGoodsSold
Research and development12 months2011-01-01 to 2011-12-31$124.8mus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative12 months2011-01-01 to 2011-12-31$74.3mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income12 months2011-01-01 to 2011-12-31$32.1mus-gaap:OperatingIncomeLoss
Interest expense12 months2011-01-01 to 2011-12-31$0us-gaap:InterestExpense
Income tax12 months2011-01-01 to 2011-12-31$15.8mus-gaap:IncomeTaxExpenseBenefit
Net income12 months2011-01-01 to 2011-12-31$23.0mus-gaap:NetIncomeLoss
Diluted EPS12 months2011-01-01 to 2011-12-31$0.64us-gaap:EarningsPerShareDiluted
Basic EPS12 months2011-01-01 to 2011-12-31$0.65us-gaap:EarningsPerShareBasic
Diluted shares (weighted)12 months2011-01-01 to 2011-12-3136,206,052 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow12 months2011-01-01 to 2011-12-31$14.6mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure12 months2011-01-01 to 2011-12-31$54.0mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2011-12-31$143.9mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2011-12-31$254.4mus-gaap:AssetsCurrent
Total assetsAt period end2011-12-31$546.9mus-gaap:Assets
Current liabilitiesAt period end2011-12-31$71.1mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2011-12-31$130.1mus-gaap:Liabilities
Long-term debtAt period end2011-12-31$54.1mus-gaap:LongTermDebtNoncurrent
Shareholders' equityAt period end2011-12-31$414.2mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001367644-12-000012. Last ingested by Listed: Nov 4, 2026, 16:51 ET. Listed shows no prices and gives no investment advice.